194 related articles for article (PubMed ID: 14647246)
21. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.
Morrison VA; Haake RJ; Weisdorf DJ
Am J Med; 1994 Jun; 96(6):497-503. PubMed ID: 8017446
[TBL] [Abstract][Full Text] [Related]
22. Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.
Saavedra S; Jarque I; Sanz GF; Moscardó F; Jiménez C; Martín G; Plumé G; Regadera A; Martínez J; De La Rubia J; Acosta B; Pemán J; Pérez-Bellés C; Gobernado M; Sanz MA
Clin Microbiol Infect; 2002 Nov; 8(11):725-33. PubMed ID: 12445010
[TBL] [Abstract][Full Text] [Related]
23. Infection in the bone marrow transplant recipient.
Walter EA; Bowden RA
Infect Dis Clin North Am; 1995 Dec; 9(4):823-47. PubMed ID: 8747768
[TBL] [Abstract][Full Text] [Related]
24. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
25. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.
Hassan IA; Chopra R; Swindell R; Mutton KJ
Bone Marrow Transplant; 2003 Jul; 32(1):73-7. PubMed ID: 12815481
[TBL] [Abstract][Full Text] [Related]
26. Infections and immunodeficiency in bone marrow transplantation.
Tutschka PJ
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S22-9. PubMed ID: 3041357
[TBL] [Abstract][Full Text] [Related]
27. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
Aksu G; Ruhi MZ; Akan H; Bengisun S; Ustün C; Arslan O; Ozenci H
Bone Marrow Transplant; 2001 Jan; 27(2):201-5. PubMed ID: 11281391
[TBL] [Abstract][Full Text] [Related]
28. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
29. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Bone Marrow Transplant; 1998 Oct; 22(8):795-800. PubMed ID: 9827978
[TBL] [Abstract][Full Text] [Related]
30. Neosartorya fischeri: an invasive fungal pathogen in an allogeneic bone marrow transplant patient.
Lonial S; Williams L; Carrum G; Ostrowski M; McCarthy P
Bone Marrow Transplant; 1997 Apr; 19(7):753-5. PubMed ID: 9156256
[TBL] [Abstract][Full Text] [Related]
31. Infections in adults undergoing unrelated donor bone marrow transplantation.
Williamson EC; Millar MR; Steward CG; Cornish JM; Foot AB; Oakhill A; Pamphilon DH; Reeves B; Caul EO; Warnock DW; Marks DI
Br J Haematol; 1999 Mar; 104(3):560-8. PubMed ID: 10086795
[TBL] [Abstract][Full Text] [Related]
32. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients.
Aljurf M; Gyger M; Alrajhi A; Sahovic E; Chaudhri N; Musa M; Ayoub O; Seth P; Aslam M; Al-Fiar F
Bone Marrow Transplant; 1999 Sep; 24(5):551-4. PubMed ID: 10482941
[TBL] [Abstract][Full Text] [Related]
33. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
34. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
35. Tuberculosis in blood and marrow transplant recipients.
Yuen KY; Woo PC
Hematol Oncol; 2002 Jun; 20(2):51-62. PubMed ID: 12111868
[TBL] [Abstract][Full Text] [Related]
36. [Infections of the central nervous system in malignant hemopathies].
Escudier E; Cordonnier C; Poirier J
Rev Neurol (Paris); 1986; 142(2):116-25. PubMed ID: 3726388
[TBL] [Abstract][Full Text] [Related]
37. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
Mossad SB; Longworth DL; Goormastic M; Serkey JM; Keys TF; Bolwell BJ
Bone Marrow Transplant; 1996 Aug; 18(2):265-71. PubMed ID: 8864433
[TBL] [Abstract][Full Text] [Related]
38. Bacteriological infections during the first hundred days of allogenic bone marrow transplantation--experience from Oman.
Ghosh K; Shenoy AK; Al-Mahrooqi Z
J Assoc Physicians India; 2002 Jul; 50():910-2. PubMed ID: 12126346
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature.
Martino R; Martínez C; Brunet S; Sureda A; López R; Domingo-Albós A
Bone Marrow Transplant; 1996 Oct; 18(4):809-12. PubMed ID: 8899202
[TBL] [Abstract][Full Text] [Related]
40. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
